Table S1 from Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in <i>ALK</i>-Rearranged NSCLC Article Swipe
Related Concepts
Cancer research
ALK inhibitor
Chemistry
Anaplastic lymphoma kinase
Molecular biology
Medicine
Internal medicine
Biology
Lung cancer
Malignant pleural effusion
Ka‐Won Noh
,
Insuk Sohn
,
Ji‐Young Song
,
Hyun‐Tae Shin
,
Yu-Jin Kim
,
Kyungsoo Jung
,
Minjung Sung
,
Mingi Kim
,
Sungbin An
,
Joungho Han
,
Se‐Hoon Lee
,
Mi‐Sook Lee
,
Yoon‐La Choi
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22469523
· OA: W4362405822
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22469523
· OA: W4362405822
<p>Clinical characteristics of ALK-rearranged and ALK-negative NSCLC patients</p>
Related Topics
Finding more related topics…